Transgene Biotek Ltd
Transgene Biotek Ltd Live Price Chart
Transgene Biotek Ltd Technicals
| 20 Day | ₹ 2.332 |
| 50 Day | ₹ 2.727 |
| 100 Day | ₹ 3.175 |
| 200 Day | ₹ 3.813 |
| 20 Day | ₹ 2.358 |
| 50 Day | ₹ 2.740 |
| 100 Day | ₹ 3.352 |
| 200 Day | ₹ 3.820 |
Transgene Biotek Ltd Performance
| Previous Close | ₹ 2.07 |
| High | ₹ 2.34 |
| Volume | 111921 |
| 52W Range | ₹ 1.83 - ₹ 5.26 |
| Open | ₹ 2.12 |
| Low | ₹ 2.1 |
| Market Cap | ₹ 23 Cr |
Transgene Biotek Ltd Fundamentals
| ROCE | -11.141 |
| P/E Ratio | -10.290 |
| P/B Ratio | 0.000 |
| Industry P/E | 0.000 |
| Debt to Equity | 75.207 |
| ROE | 19.407 |
| EPS | -0.210 |
| Dividend Yield | 0.000 |
| Book Value | -1.105 |
| Face Value | 10.000 |
Transgene Biotek Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 1.0442 | 0.4176 | 0.2305 | 0.2992273 | 0.4364483 |
| Total Expenses | 1.7203 | 1.0731 | 6.2372 | 10.7012318 | 10.8695949 |
| Profit After Tax | -0.6761 | -0.6555 | -6.0067 | -10.4020045 | -10.4331466 |
Transgene Biotek Ltd Shareholding Pattern
| Promoter Holdings | 23.637 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 71.855 % |
| Others - | 4.508 % |
About Transgene Biotek Ltd
History of Transgene Biotek Ltd
Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc. The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively. Transgene Biotek's products are exported to Africa, Russia, China, Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility costing Rs. 30 crore at the Anrich Industrial Area, Bollaram. TBL is working of four new plants comprising of Oral deliver of proteins and peptides; DNA vaccines; fusion proteins and bio therapeutics. The new project is funded through preferential offer to Batterymarch Financial Management USA and Other Financial Institutions (FIs). The Company absorbed the transfer of technology from RBB Inc, USA for the manufacture and marketing of Erythropoietin during year 2003. The Scheme of Arrangement for Amalgamatio ...
